Cutler Group’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-17
Closed 4880
2022
Q2
$0 Hold
17
﹤0.01% 4936
2022
Q1
$0 Hold
17
﹤0.01% 5283
2021
Q4
$0 Hold
17
﹤0.01% 5342
2021
Q3
$0 Hold
17
﹤0.01% 5666
2021
Q2
$0 Sell
17
-41
-71% -$2.03K ﹤0.01% 5639
2021
Q1
$3K Buy
58
+8
+16% +$530 ﹤0.01% 4640
2020
Q4
$3K Buy
50
+5
+11% +$587 ﹤0.01% 3895
2020
Q3
$8K Hold
45
﹤0.01% 3122
2020
Q2
$12K Sell
45
-330
-88% -$77K ﹤0.01% 2726
2020
Q1
$66K Buy
+375
New +$80.4K ﹤0.01% 1563
2019
Q4
Sell
-133
Closed -$24.5K 3955
2019
Q3
$15K Buy
133
+8
+6% +$1.21K ﹤0.01% 2355
2019
Q2
$20K Buy
125
+111
+793% +$21.1K ﹤0.01% 2195
2019
Q1
$3K Sell
14
-619
-98% -$157K ﹤0.01% 3153
2018
Q4
$171K Buy
633
+616
+3,624% +$178K 0.02% 721
2018
Q3
$7K Sell
17
-160
-90% -$74.9K ﹤0.01% 2837
2018
Q2
$83K Buy
+177
New +$93.6K 0.01% 1269
2017
Q4
Sell
-365
Closed -$165K 4851
2017
Q3
$152K Buy
+365
New +$112K 0.01% 1350

Other funds holding ASMB

Cutler Group's ASMB Position: Q3 2022 in Review

Cutler Group sold out of Assembly Biosciences (ASMB) in Q3 2022, closing a stake of 17 shares.

Cutler Group first reported a position in ASMB in Q3 2017 and held it in 17 quarters. The position peaked at $171K in Q4 2018. 50 funds tracked by Wall St. Rank hold ASMB as of Q3 2022.

  • Cutler Group reported no remaining Assembly Biosciences position as of Q3 2022 after selling out during the quarter.
  • Cutler Group sold 17 Assembly Biosciences shares in Q3 2022.
  • Cutler Group first reported a position in Assembly Biosciences in Q3 2017 and held it in 17 quarters.
  • Cutler Group's Assembly Biosciences position peaked at $171K in Q4 2018.
  • 50 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.